JOEL VILES: Open Payments
NPI 1194210054 · MCMINNVILLE, OR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$395 in 22 payments from 6 companies in 2025. Trend: 2023 $0 · 2024 $359 · 2025 $395
Food & beverage: $296Education: $99
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 16 | $264 |
| ABBVIE INC. | 2 | $48 |
| GENZYME CORPORATION | 1 | $27 |
| Genentech USA, Inc. | 1 | $24 |
| Galderma Laboratories, L.P. | 1 | $18 |
| Regeneron Healthcare Solutions, Inc. | 1 | $16 |
Products named: TREMFYA, DUPIXENT, SKYRIZI, Xolair, RINVOQ, NEMLUVIO.
Industry payments across OR — which companies pay providers there.
